GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q1 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $258,000 | +7.9% | 6,121 | -1.4% | 0.02% | 0.0% |
Q4 2016 | $239,000 | -18.7% | 6,211 | -8.7% | 0.02% | -19.0% |
Q3 2016 | $294,000 | +10.9% | 6,806 | +11.2% | 0.02% | +5.0% |
Q2 2016 | $265,000 | +2.7% | 6,121 | -3.7% | 0.02% | +5.3% |
Q1 2016 | $258,000 | -10.1% | 6,353 | -10.7% | 0.02% | -9.5% |
Q4 2015 | $287,000 | -96.7% | 7,118 | -96.6% | 0.02% | -95.6% |
Q2 2015 | $8,651,000 | -11.2% | 207,696 | -1.7% | 0.48% | +10.6% |
Q1 2015 | $9,746,000 | +3.3% | 211,188 | -4.3% | 0.44% | +1.9% |
Q4 2014 | $9,432,000 | -17.5% | 220,674 | -11.3% | 0.43% | -16.1% |
Q3 2014 | $11,433,000 | -10.9% | 248,698 | +3.6% | 0.51% | -8.8% |
Q2 2014 | $12,835,000 | +2.7% | 240,005 | +2.6% | 0.56% | -2.1% |
Q1 2014 | $12,500,000 | +4.0% | 233,946 | +4.0% | 0.57% | +8.8% |
Q4 2013 | $12,014,000 | +10.9% | 225,018 | +4.2% | 0.52% | +1.2% |
Q3 2013 | $10,831,000 | +3.0% | 215,881 | +2.6% | 0.52% | -2.8% |
Q2 2013 | $10,512,000 | – | 210,369 | – | 0.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |